ArticleJournal of medical case reports2026
The uninvited guest: live fasciola hepatica as a cause of obstructive jaundice-a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatic fascioliasis is a zoonotic infection caused by Fasciola hepatica. It is underdiagnosed due to its non-specific clinical presentation and limited diagnostic tools in many healthcare settings. Human infections, though uncommon, are rising in endemic areas. CASE PRESENTATION: We report a 40-year-old South Asian female presenting with a 3-month history of vague right hypochondrial pain, nausea, and poor appetite. Laboratory tests showed cholestatic jaundice. Abdominal ultrasound revealed gallbladder sludge and a dilated common bile duct. ERCP was performed and revealed live Fasciola hepatica worms in the biliary tree. Post-extraction, she was treated with albendazole with complete resolution of symptoms and normalization of liver biochemistry.
conclusionsThis case highlights the importance of considering hepatic fascioliasis in patients with atypical hepatobiliary symptoms, especially in endemic regions. ERCP played a pivotal role in both diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.